Forbion invests in transformative biotech and sustainable solutions that drive positive societal and environmental impact while delivering financial returns. Their focus spans human health (drug development) and planetary health (food, agriculture, materials, and environmental tech). The firm emphasizes ESG principles, patient impact, and societal benefits across 11 funds managing €5bn+.
Preferred startup development maturity for initial funding deployment.
Groundbreaking biotech innovations and sustainable solutions improving human and planetary health, including drug development, bioeconomy, and environmental technologies.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
